BACKGROUND: 12-Lipoxygenase (12-LO) products of arachidonate metabolism have growth and chemotactic effects in vascular smooth muscle cells. We have also recently demonstrated increased 12-LO mRNA and protein expression in the neointima of balloon-injured rat carotid arteries. In this study, we evaluated whether 12-LO activation plays a role in neointimal thickening in this rat model by using a specific ribozyme (Rz) directed to rat 12-LO. METHODS AND RESULTS: We designed a chimeric DNA-RNA hammerhead Rz to cleave rat leukocyte-type 12-LO mRNA. This Rz dose-dependently cleaved a 166-nucleotide target 12-LO mRNA substrate in vitro and reduced 12-LO mRNA and protein expression in rat vascular smooth muscle cells. A control mutant Rz (MRz) with a point mutation in the catalytic site was inactive. To test the in vivo efficacy of the 12-LO Rz, the left common carotid arteries of rats were injured with a balloon catheter. The distal half of the injured arteries was treated with Rz or MRz mixed with lipofectin. The proximal half received only lipofectin. Twelve days after injury, intima-to-media ratios were significantly lower in the Rz-treated sections than in untreated sections from the same rat (0.742+/-0.16 versus 1.749+/-0.12, P:<0.001). In contrast, the MRz had no significant effect. CONCLUSIONS: These results indicate the important role of the leukocyte-type 12-LO pathway in restenosis in response to injury.
BACKGROUND: 12-Lipoxygenase (12-LO) products of arachidonate metabolism have growth and chemotactic effects in vascular smooth muscle cells. We have also recently demonstrated increased 12-LO mRNA and protein expression in the neointima of balloon-injured rat carotid arteries. In this study, we evaluated whether 12-LO activation plays a role in neointimal thickening in this rat model by using a specific ribozyme (Rz) directed to rat 12-LO. METHODS AND RESULTS: We designed a chimeric DNA-RNA hammerhead Rz to cleave rat leukocyte-type 12-LO mRNA. This Rz dose-dependently cleaved a 166-nucleotide target 12-LO mRNA substrate in vitro and reduced 12-LO mRNA and protein expression in rat vascular smooth muscle cells. A control mutant Rz (MRz) with a point mutation in the catalytic site was inactive. To test the in vivo efficacy of the 12-LO Rz, the left common carotid arteries of rats were injured with a balloon catheter. The distal half of the injured arteries was treated with Rz or MRz mixed with lipofectin. The proximal half received only lipofectin. Twelve days after injury, intima-to-media ratios were significantly lower in the Rz-treated sections than in untreated sections from the same rat (0.742+/-0.16 versus 1.749+/-0.12, P:<0.001). In contrast, the MRz had no significant effect. CONCLUSIONS: These results indicate the important role of the leukocyte-type 12-LO pathway in restenosis in response to injury.
Authors: Angela M Taylor; Ross Hanchett; Rama Natarajan; Catherine C Hedrick; Scott Forrest; Jerry L Nadler; Coleen A McNamara Journal: Arterioscler Thromb Vasc Biol Date: 2005-07-21 Impact factor: 8.311
Authors: Nikhlesh K Singh; Dong Van Quyen; Venkatesh Kundumani-Sridharan; Peter C Brooks; Gadiparthi N Rao Journal: J Biol Chem Date: 2010-03-29 Impact factor: 5.157
Authors: M J Coffey; R Natarajan; P H Chumley; B Coles; P R Thimmalapura; M Nowell; H Kühn; M J Lewis; B A Freeman; V B O'Donnell Journal: Proc Natl Acad Sci U S A Date: 2001-06-26 Impact factor: 11.205
Authors: Harihara S K Potula; Dong Wang; Dong Van Quyen; Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Manjula Karpurapu; Edwards A Park; Wayne C Glasgow; Gadiparthi N Rao Journal: J Biol Chem Date: 2009-09-07 Impact factor: 5.157
Authors: Hamid Deliri; Nahum Meller; Ajay Kadakkal; Rohit Malhotra; Jordan Brewster; Amanda C Doran; Hong Pei; Stephanie N Oldham; Marcus D Skaflen; James C Garmey; Coleen A McNamara Journal: Arterioscler Thromb Vasc Biol Date: 2010-10-14 Impact factor: 10.514
Authors: Kamalika Mukherjee; Chi Young Song; Anne M Estes; Ahmad N Dhodi; Benjamin H Ormseth; Ji Soo Shin; Frank J Gonzalez; Kafait U Malik Journal: J Am Heart Assoc Date: 2018-09-18 Impact factor: 5.501